ArticleJournal of acquired immune deficiency syndromes (1999)2020

Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.

Lucia R I Millham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.